MLTX - Volatility Contraction Pattern - Breakout -DailyMLTX - Chart formed Volatility Contraction Pattern (VCP) gave breakout with good volume.
Need to see follow-up buying for target of 63, it can retest 50 levels
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−25.44 MXN
−611.59 M MXN
0.00 MXN
52.84 M
About MoonLake Immunotherapeutics
Sector
CEO
Jorge Santos da Silva
Headquarters
Zug
Website
Founded
2021
FIGI
BBG01HDYLCZ4
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MLTX/N is 1,074.20 MXN — it has increased by 9.94% in the past 24 hours. Watch MOONLAKE IMMUNOTHERAPEUTICS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange MOONLAKE IMMUNOTHERAPEUTICS stocks are traded under the ticker MLTX/N.
We've gathered analysts' opinions on MOONLAKE IMMUNOTHERAPEUTICS future price: according to them, MLTX/N price has a max estimate of 2,175.84 MXN and a min estimate of 1,108.07 MXN. Watch MLTX/N chart and read a more detailed MOONLAKE IMMUNOTHERAPEUTICS stock forecast: see what analysts think of MOONLAKE IMMUNOTHERAPEUTICS and suggest that you do with its stocks.
MLTX/N reached its all-time high on Dec 10, 2024 with the price of 1,074.20 MXN, and its all-time low was 750.00 MXN and was reached on Dec 1, 2023. View more price dynamics on MLTX/N chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MLTX/N stock is 9.04% volatile and has beta coefficient of 1.62. Track MOONLAKE IMMUNOTHERAPEUTICS stock price on the chart and check out the list of the most volatile stocks — is MOONLAKE IMMUNOTHERAPEUTICS there?
Today MOONLAKE IMMUNOTHERAPEUTICS has the market capitalization of 67.03 B, it has increased by 2.46% over the last week.
Yes, you can track MOONLAKE IMMUNOTHERAPEUTICS financials in yearly and quarterly reports right on TradingView.
MOONLAKE IMMUNOTHERAPEUTICS is going to release the next earnings report on Mar 24, 2025. Keep track of upcoming events with our Earnings Calendar.
MLTX/N earnings for the last quarter are −11.03 MXN per share, whereas the estimation was −8.58 MXN resulting in a −28.60% surprise. The estimated earnings for the next quarter are −12.19 MXN per share. See more details about MOONLAKE IMMUNOTHERAPEUTICS earnings.
MOONLAKE IMMUNOTHERAPEUTICS revenue for the last quarter amounts to 0.00 MXN, matching the estimated figure, and no changes in revenue are expected for the next quarter.
MLTX/N net income for the last quarter is −697.32 M MXN, while the quarter before that showed −445.10 M MXN of net income which accounts for −56.66% change. Track more MOONLAKE IMMUNOTHERAPEUTICS financial stats to get the full picture.
No, MLTX/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 50.00 employees. See our rating of the largest employees — is MOONLAKE IMMUNOTHERAPEUTICS on this list?
Like other stocks, MLTX/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MOONLAKE IMMUNOTHERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.